Cansortium Inc. (CNTMF)

0.1879 -0.0041 (-2.16%) As of 01:13PM EDT. Market open.

Cansortium Inc.

82 North East 26th Street
Suite 110
Miami, FL 33137
United States
(833) 735-8368
https://getfluent.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. William M. Smith	Executive Chairman	200k	N/A	N/A
Mr. Robert Beasley	CEO & Director	560k	N/A	N/A
Ms. Samantha Senne Hymes	Executive Vice President of Operations	213.85k	N/A	N/A
Mr. Victor Bindi	Director of Sales	203.85k	N/A	N/A
Ms. Liora Boudin	Corporate Controller	142.31k	N/A	N/A
Mr. Jeffrey Robert Batliner	Chief Financial Officer	N/A	N/A	1965
Dr. Jennifer McCafferty-Fernandez	Chief Science Officer	N/A	N/A	N/A
Mr. Jeffrey Reath	Consultant	197.9k	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in Florida, Pennsylvania, and Texas. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, and edibles under the Fluent brand name. It also sells various third-party branded medical cannabis products. The company was incorporated in 2018 and is headquartered in Miami, Florida.

Corporate Governance

Cansortium Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.